3D printing and continuous flow chemistry technology to advance pharmaceutical manufacturing in developing countries
- PMID: 34909056
- PMCID: PMC7511217
- DOI: 10.1016/j.arabjc.2020.09.020
3D printing and continuous flow chemistry technology to advance pharmaceutical manufacturing in developing countries
Abstract
The realization of a downward spiralling of diseases in developing countries requires them to become self-sufficient in pharmaceutical products. One of the ways to meet this need is by boosting the local production of active pharmaceutical ingredients and embracing enabling technologies. Both 3D printing and continuous flow chemistry are being exploited rapidly and they are opening huge avenues of possibilities in the chemical and pharmaceutical industries due to their well-documented benefits. The main barrier to entry for the continuous flow chemistry technique in low-income settings is the cost of set-up and maintenance through purchasing of spare flow reactors. This review article discusses the technical considerations for the convergence of state-of-the-art technologies, 3D printing and continuous flow chemistry for pharmaceutical manufacturing applications in developing countries. An overview of the 3D printing technique and its application in fabrication of continuous flow components and systems is provided. Finally, quality considerations for satisfying regulatory requirements for the approval of 3D printed equipment are underscored. An in-depth understanding of the interrelated aspects in the implementation of these technologies is crucial for the realization of sustainable, good quality chemical reactionware.
Keywords: 3D printing; Affordable; Continuous flow chemistry; Developing countries; Pharmaceutical manufacturing; Quality control.
© 2020 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Aguiar R.M., Leão R.A.C., Mata A., Cantillo D., Kappe C.O., Miranda L.S.M., De Souza R.O.M.A. Continuous-flow protocol for the synthesis of enantiomerically pure intermediates of anti epilepsy and anti tuberculosis active pharmaceutical ingredients. Org. Biomol. Chem. 2019;17:1552–1557. doi: 10.1039/C8OB03088J. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources